Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.
Press releases published on April 23, 2025
Palvella Therapeutics Announces Abstract Highlighting the Estimated Diagnosed Prevalence and Annual Incidence of Lymphatic Malformations in the U.S. Accepted for Poster Presentation at the 82nd Annual Meeting of the Society for Investigative Dermatology
GlobeNewswire
·
April 23, 2025
Quantitative analysis of medical claims indicates an estimated 44,553 to 92,967 diagnosed U.S. patients with lymphatic malformations (LMs) with cutaneous involvement Estimates of annual incidence of LMs with cutaneous involvement to be highlighted in the …
Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
GlobeNewswire
·
April 23, 2025
SAN CARLOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …
Silvaco Announces Date of First Quarter 2025 Financial Results Conference Call
GlobeNewswire
·
April 23, 2025
SANTA CLARA, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO, “Silvaco”), a provider of TCAD, EDA software, and SIP solutions that enable innovative semiconductor design and digital twin modeling through AI software and …
Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025
GlobeNewswire
·
April 23, 2025
Data from Cohorts 1-3 of trial to be presented in an oral session and poster at the Society for Investigative Dermatology (SID) 2025 Annual Meeting Company to discuss data on its first quarter 2025 business update conference call and webcast scheduled for …
Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025
GlobeNewswire
·
April 23, 2025
SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025
GlobeNewswire
·
April 23, 2025
WEST LAFAYETTE, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research …
Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting
GlobeNewswire
·
April 23, 2025
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 23, 2025
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on January 31, 2025, the company issued inducement awards …
Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients
GlobeNewswire
·
April 23, 2025
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the United States Patent and …
Sight Sciences Announces the Release of its Sustainability Report
GlobeNewswire
·
April 23, 2025
MENLO PARK, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today …
Dragonfly Energy Announces First Quarter 2025 Preliminary Net Sales and Adjusted EBITDA
GlobeNewswire
·
April 23, 2025
RENO, Nev., April 23, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), an industry leader in energy storage and battery technology, today announced preliminary first quarter 2025 Net Sales and …
Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025
GlobeNewswire
·
April 23, 2025
NEEDHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …
Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts
GlobeNewswire
·
April 23, 2025
First U.S. patient dosed in ATALANTA-1 study of GLPG5101 Mantle cell lymphoma (MCL), a high-unmet-need hematological malignancy, selected as lead indication for the GLPG5101 program; Pivotal development planned to start in 2026 and aiming for approval in …
Galapagos rapporteert resultaten over het eerste kwartaal van 2025, recente hoogtepunten en verwachtingen op korte termijn
GlobeNewswire
·
April 23, 2025
Eerste Amerikaanse patiënt gedoseerd in ATALANTA-1 studie met GLPG5101 Mantelcellymfoom (MCL), een hematologische maligniteit met een hoge onvervulde behoefte, geselecteerd als hoofdindicatie voor het GLPG5101-programma; pivotale ontwikkeling gepland voor …
Verses AI Inc. Announces Proposed Public Offering of Securities
GlobeNewswire
·
April 23, 2025
VANCOUVER, British Columbia, April 23, 2025 (GLOBE NEWSWIRE) -- Verses AI Inc. (CBOE: VERS)(OTCQB: VRSSD) (“Verses” or the “Company”) is pleased to announce an offering (the “Offering”) of securities in Canada under the base shelf prospectus of the Company …
Oxford Instruments NanoScience installs two of its largest modular Dilution Refrigerators
EIN Presswire
·
April 23, 2025
Oxford Instruments NanoScience announces that it has installed the first two of a number of its largest modular dilution refrigerators, the ProteoxQX. OXFORD, UNITED KINGDOM, April 23, 2025 /EINPresswire.com/ -- Oxford Instruments NanoScience is …
GWM Unveils its Global Strategy at Auto Shanghai 2025: From China’s GWM to a Global Brand
GlobeNewswire
·
April 23, 2025
Baoding, China , April 23, 2025 (GLOBE NEWSWIRE) -- On April 23, 2025, the 21st Shanghai International Automobile Industry Exhibition officially opened. GWM unveiled its exhibition at Hall 7.1, covering over 6,500 square meters, presenting two core product …
Mounfit Under Review: Natural Mounjaro Ingredients Recipe to Lose Weight Safely
GlobeNewswire
·
April 23, 2025
Aurora, Colorado, April 23, 2025 (GLOBE NEWSWIRE) -- Introduction Understanding the Modern Weight Loss Struggle In 2025, millions continue to struggle with stubborn weight gain, not because they lack willpower, but because the rules of metabolism have …
Best SARMS for Cutting and Bulking to Buy 2025 - Best SARMS for Sale for Muscle Growth, Fat Loss and Bodybuilding- By CrazyBulk
GlobeNewswire
·
April 23, 2025
Albany, New York, April 23, 2025 (GLOBE NEWSWIRE) -- If you’re looking to transform your physique with lean muscle growth, SARMs (Selective Androgen Receptor Modulators) are incredibly popular. Bodybuilders are buying SARMs for bulking and cutting and …
Sarms Vs Steroids – The Best Sarms And Legal Steroids For Cutting, Bulking And Bodybuilding In 2025 Tested And Rated – By Crazy Bulk.
GlobeNewswire
·
April 23, 2025
New York City, April 23, 2025 (GLOBE NEWSWIRE) -- SARMs are a rather new proposition on the market compared to steroids. An enthusiast of the fitness culture would admit to having heard about SARMs or steroids at some point. They enjoy a better …